Left ventricular hypertrophy is associated with inflammation in sodium loaded subtotal nephrectomized rats

Biomedical Research

Volumn 32, Issue 2, 2011, Pages 83-90

  Moriguchi, Yoshiyuki ^a   Yogo, Kenji ^a   Aizawa, Ken ^a   Serizawa, Ken ichi ^a   Tashiro, Yoshihito ^a   Yorozu, Keigo ^a   Ishizuka, Nobuhiko ^a   Iwabuchi, Sadahiro ^b   Kitamura, Hidemitsu ^b   Nishimura, Takashi ^b  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; INTERLEUKIN 6; N(G),N(G) DIMETHYLARGININE; PARATHYROID HORMONE; PHOSPHATE; SODIUM CHLORIDE;

AMINO ACID BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; GLOMERULOSCLEROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HYPERTENSION; INFLAMMATORY CELL; KIDNEY FIBROSIS; MALE; NEPHRECTOMY; NONHUMAN; PHOSPHATE BLOOD LEVEL; RAT; RISK FACTOR;

ANIMALS; ARGININE; CREATININE; DISEASE MODELS, ANIMAL; FIBROSIS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; NEPHRECTOMY; PARATHYROID HORMONE; PHOSPHATES; RATS; RATS, WISTAR; RISK FACTORS; SCLEROSIS; SODIUM CHLORIDE;

RATTUS;

EID: 79957777247     PISSN: 03886107     EISSN: 1880313X     Source Type: Journal    
DOI: 10.2220/biomedres.32.83     Document Type: Article

References (27)

1. Amann K, Ritz E, Wiest G, Klaus G and Mall G (1994) A role of parathyroid hormone for the activation of cardiac fi-broblasts in uremia. J Am Soc Nephrol 4, 1814-1819.
2. Appel LJ (2004) Beyond (or back to) traditional risk factors: preventing cardiovascular disease in patients with chronic kidney disease. Ann Intern Med 140, 60-61.
3. Chana RS, Martin J, Rahman EU and Wheeler DC (2003) Monocyte adhesion to mesangial matrix modulates cytokine and metalloproteinase production. Kidney Int 63, 889-898.
4. Chen MF, Li YJ, Yang TL, Lou B and Xie XM (2009) Losartan inhibits monocytic adhesion induced by ADMA via downregulation of chemokine receptors in monocytes. Eur J Clin Pharmacol 65, 457-464.
5. Friedman AN, Hunsicker LG, Selhub J and Bostom AG (2005) C-reactive protein as a predictor of total arteriosclerotic out-comes in type 2 diabetic nephropathy. Kidney Int 68, 773-778.
6. Fujii H, Kim JI, Abe T, Umezu M and Fukagawa M (2007) Relationship between parathyroid hormone and cardiac ab-normalities in chronic dialysis patients. Intern Med 46, 1507-1512.
7. Haugen E, Gan LM, Isic A, Skommevik T and Fu M (2008) Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients. Exp Clin Cardiol 13, 19-24.
8. Huang MY, Chaturvedi LS, Koul S and Koul HK (2005) Ox-alate stimulates IL-6 production in HK-2 cells, a line of hu-man renal proximal tubular epithelial cells. Kidney Int 68, 497-503.
9. Kendrick J and Chonchol MB (2008) Nontraditional risk fac-tors for cardiovascular disease in patients with chronic kid-ney disease. Nat Clin Pract Nephrol 4, 672-681.
10. Kielar ML, John R, Bennett M, Richardson JA, Shelton JM, Chen L, Jeyarajah DR, Zhou XJ, Zhou H, Chiquett B, Nagami GT and Lu CY (2005) Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16, 3315-3325.
11. Lai KN, Leung JC, Chan LY, Guo H and Tang SC (2007) In-teraction between proximal tubular epithelial cells and infil-trating monocytes/T cells in the proteinuric state. Kidney Int 71, 526-538.
12. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A and Klag MJ (2002) Traditional cardiovascular dis-ease risk factors in dialysis patients compared with the gen-eral population: the CHOICE Study. J Am Soc Nephrol 13, 1918-1927.
13. Matsumoto Y, Ueda S, Yamagishi S, Matsuguma K, Shibata R, Fukami K, Matsuoka H, Imaizumi T and Okuda S (2007) Dimethylarginine dimethylaminohydrolase prevents progres-sion of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol 18, 1525-1533.
14. Meinitzer A, Seelhorst U, Wellnitz B, Halwachs-Baumann G, Boehm BO, Winkelmann BR and Marz W (2007) Asymmet-rical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovas-cular Health study). Clin Chem 53, 273-283.
15. Melendez GC, McLarty JL, Levick SP, Du Y, Janicki JS and Brower GL (2010) Interleukin 6 mediates myocardial fibro-sis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 56, 225-231.
16. Palm F, Onozato ML, Luo Z and Wilcox CS (2007) Dimeth-ylarginine dimethylaminohydrolase (DDAH): expression, reg-ulation, and function in the cardiovascular and renal systems. Am J Physiol Heart Circ Physiol 293, H3227-3245.
17. Park CW, Shin YS, Kim CM, Lee SY, Yu SE, Kim SY, Choi EJ, Chang YS and Bang BK (2002) Increased C-reactive protein following hemodialysis predicts cardiac hypertrophy in chronic hemodialysis patients. Am J Kidney Dis 40, 1230-1239.
18. Reis SE, Olson MB, Fried L, Reeser V, Mankad S, Pepine CJ, Kerensky R, Merz CN, Sharaf BL, Sopko G, Rogers WJ and Holubkov R (2002) Mild renal insufficiency is associat-ed with angiographic coronary artery disease in women. Cir-culation 105, 2826-2829.
19. Ritz E and McClellan WM (2004) Overview: increased car-diovascular risk in patients with minor renal dysfunction: an emerging issue with far-reaching consequences. J Am Soc Nephrol 15, 513-516.
20. Schluter KD and Piper HM (1998) Cardiovascular actions of parathyroid hormone and parathyroid hormone-related pep-tide. Cardiovasc Res 37, 34-41.
21. Tsutamoto T, Hisanaga T, Wada A, Maeda K, Ohnishi M, Fukai D, Mabuchi N, Sawaki M and Kinoshita M (1998) In-terleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in pa-tients with congestive heart failure. J Am Coll Cardiol 31, 391-398.
22. Ueda S, Yamagishi S, Matsumoto Y, Kaida Y, Fujimi-Hayashida A, Koike K, Tanaka H, Fukami K and Okuda S (2009) Involvement of asymmetric dimethylarginine (ADMA) in glomerular capillary loss and sclerosis in a rat model of chronic kidney disease (CKD). Life Sci 84, 853-856.
23. Veresh Z, Racz A, Lotz G and Koller A (2008) ADMA impairs nitric oxide-mediated arteriolar function due to in-creased superoxide production by angiotensin II-NAD(P)H oxidase pathway. Hypertension 52, 960-966.
24. Wassmann S, Stumpf M, Strehlow K, Schmid A, Schieffer B, Bohm M and Nickenig G (2004) Interleukin-6 induces oxi-dative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor. Circ Res 94, 534-541.
25. Zhang H, Jiang Z, Chang J, Li X, Zhu H, Lan HY, Zhou SF and Yu X (2009) Role of NAD(P)H oxidase in transforming growth factor-beta1-induced monocyte chemoattractant pro-tein-1 and interleukin-6 expression in rat renal tubular epithelial cells. Nephrology (Carlton) 14, 302-310.
26. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J and Boger R (2001) Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage re-nal disease: a prospective study. Lancet 358, 2113-2117.
27. Zoccali C, Mallamaci F, Maas R, Benedetto FA, Tripepi G, Malatino LS, Cataliotti A, Bellanuova I and Boger R (2002) Left ventricular hypertrophy, cardiac remodeling and asym-metric dimethylarginine (ADMA) in hemodialysis patients. Kidney Int 62, 339-345.